242 related articles for article (PubMed ID: 18667033)
1. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
Yoshida R; Yoneda Y; Kuriyama M; Kubota T
J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
[TBL] [Abstract][Full Text] [Related]
3. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
4. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
Yoneda Y; Yoshida R
J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
[TBL] [Abstract][Full Text] [Related]
5. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
Tashiro-Yamaji J; Kubota T; Yoshida R
Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
Krulová M; Zajícová A; Fric J; Holán V
Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
[TBL] [Abstract][Full Text] [Related]
7. Transgene number-dependent, gene expression rate-independent rejection of Dd -, Kd-, or Dd Kd -transgened mouse skin or tumor cells from C57BL/6 Db Kb mice.
Inoue Y; Tashiro-Yamaji J; Hayashi M; Kiyonari H; Shimizu T; Ibata M; Yamana H; Kubota T; Tanigawa N; Yoshida R
Microbiol Immunol; 2011 Jun; 55(6):446-53. PubMed ID: 21434990
[TBL] [Abstract][Full Text] [Related]
8. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous rejection of intradermally transplanted non-engineered tumor cells by neutrophils and macrophages from syngeneic strains of mice.
Ibata M; Takahashi T; Shimizu T; Inoue Y; Maeda S; Tashiro-Yamaji J; Okada M; Ueda K; Kubota T; Yoshida R
Microbiol Immunol; 2011 Oct; 55(10):726-35. PubMed ID: 21806674
[TBL] [Abstract][Full Text] [Related]
10. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
11. Role of macrophage activation in allograft immunity: in vivo studies.
Debray-Sachs M; Dy M; Hamburger J
Ann Immunol (Paris); 1979; 130C(5):721-33. PubMed ID: 393160
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
[TBL] [Abstract][Full Text] [Related]
13. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study on induction of skin allograft tolerance in mice by heat shock protein 60].
Huang W; Ye Q; Huang Z; Yang D; Peng M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):993-7. PubMed ID: 18773821
[TBL] [Abstract][Full Text] [Related]
15. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
[TBL] [Abstract][Full Text] [Related]
16. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
Tsung K; Dolan JP; Tsung YL; Norton JA
Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 12 and direct cytotoxicity of spleen lymphocytes to Listeria innocua-phagocyting syngeneic macrophages in C57BL/6 and BALB/c mice.
Szeliga J; Fiuk D; Walencka M; Gościcka T
Arch Immunol Ther Exp (Warsz); 1997; 45(1):49-54. PubMed ID: 9090440
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Sinha P; Clements VK; Ostrand-Rosenberg S
Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
[TBL] [Abstract][Full Text] [Related]
19. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
[TBL] [Abstract][Full Text] [Related]
20. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
